Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
{{output}}
Introduction: Chimeric antigen receptor (CAR)-NK cells are considered safer than CAR-T cells due to their short lifetime and production of lower toxicity cytokines. By virtue of unlimited proliferative ability in vitro, NK-92 cel... ...
